Skip to content
healthcare.dev

Cyclophosphamide

NDC 65219-135, cyclophosphamide, injection, powder, for solution, from Fresenius Kabi USA, LLC.

Product NDC
65219-135
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS, ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA204555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65219-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYCLOPHOSPHAMIDE500 mg/25mL
Package NDCNDC-11Package
65219-135-20652190135201 VIAL, SINGLE-DOSE in 1 CARTON (65219-135-20) / 25 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/31986d36-a1bf-4903-93a4-ce7386241ba1
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65219-135

Use it

Look up 65219-135 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65219-135 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65219-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.